References
- Jinno J, Kamada N, Miyake M, Yamada K, Mukai T, Odomi M et al. (2008). In vitro-in vivo correlation for wet-milled tablet of poorly water-soluble cilostazol. J Control Release, 130:29–37.
- Liu P, Rong X, Laru J, van Veen B, Kiesvaara J, Hirvonen J et al. (2011). Nanosuspensions of poorly soluble drugs: preparation and development by wet milling. Int J Pharm, 411:215–222.
- Shegokar R, Müller RH. (2010). Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives. Int J Pharm, 399:129–139.
- Nikowitz K, Kása Jr P, Pintye-Hódi K, Regdon Jr G. 2011. Study of the preparation of a multiparticulate drug delivery system with a layering technique. Powder Technol, 205:155–159.
- Zhang L, Chai G, Zeng X, He H, Xu H, Tang X. (2010). Preparation of fenofibrate immediate-release tablets involving wet grinding for improved bioavailability. Drug Dev Ind Pharm, 36:1054–1063.
- Vogt M, Kunath K, Dressman JB. (2008). Dissolution enhancement of fenofibrate by micronization, cogrinding and spray-drying: comparison with commercial preparations. Eur J Pharm Biopharm, 68:283–288.
- Vasconcelos T, Sarmento B, Costa P. (2007). Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov Today, 12:1068–1075.
- Niwa T, Miura S, Danjo K. (2011). Universal wet-milling technique to prepare oral nanosuspension focused on discovery and preclinical animal studies - Development of particle design method. Int J Pharm, 405:218–227.
- Szentkuti L. 1997. Light microscopical observations on luminally administered dyes, dextrans, nanospheres and microspheres in the pre-epithelial mucus gel layer of the rat distal colon. J Contr Release, 46:233–242.
- Kürti L, Kukovecz Á, Kozma G, Ambrus R, Deli MA, Szabó-Révész P. 2011. Study of the parameters influencing the co-grinding process for the production of meloxicam nanoparticles. Powder Tech, 212:210–217.
- Sharma P, Denny WA, Garg S. (2009). Effect of wet milling process on the solid state of indomethacin and simvastatin. Int J Pharm, 380:40–48.
- Van Eerdenbrugh B, Van den Mooter G, Augustijns P. (2008). Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products. Int J Pharm, 364:64–75.
- Wu L, Zhang J, Watanabe W. (2011). Physical and chemical stability of drug nanoparticles. Adv Drug Deliv Rev, 63:456–469.
- Merisko-Liversidge E, Liversidge GG. (2011). Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology. Adv Drug Deliv Rev, 63:427–440.
- Florence AT, Hussain N. (2001). Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas. Adv Drug Deliv Rev, 50 Suppl 1:S69–S89.
- Jani P, Halbert GW, Langridge J, Florence AT. (1989). The uptake and translocation of latex nanospheres and microspheres after oral administration to rats. J Pharm Pharmacol, 41:809–812.
- LeFevre ME, Boccio AM, Joel DD. (1989). Intestinal uptake of fluorescent microspheres in young and aged mice. Proc Soc Exp Biol Med, 190:23–27.
- Wan LSC, Lai W. 1991. Factors affecting drug release from drug-coated granules prepared by fluidized-bed coating. Int J Pharm, 72:163–174.
- Pearnchob N, Bodmeier R. (2003). Dry polymer powder coating and comparison with conventional liquid-based coatings for Eudragit) RS, ethylcellulose and shellac. Eur J Pharm Biopharm, 56:363–369.
- Van Eerdenbrugh B, Stuyven B, Froyen L, Van Humbeeck J, Martens JA, Augustijns P et al. (2009). Downscaling drug nanosuspension production: processing aspects and physicochemical characterization. AAPS Pharm Sci Tech, 10:44–53.